These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

402 related articles for article (PubMed ID: 26376850)

  • 1. Identification of serum proteome signatures of locally advanced and metastatic gastric cancer: a pilot study.
    Abramowicz A; Wojakowska A; Gdowicz-Klosok A; Polanska J; Rodziewicz P; Polanowski P; Namysl-Kaletka A; Pietrowska M; Wydmanski J; Widlak P
    J Transl Med; 2015 Sep; 13():304. PubMed ID: 26376850
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of serum proteome components associated with progression of non-small cell lung cancer.
    Pietrowska M; Jelonek K; Michalak M; Roś M; Rodziewicz P; Chmielewska K; Polański K; Polańska J; Gdowicz-Kłosok A; Giglok M; Suwiński R; Tarnawski R; Dziadziuszko R; Rzyman W; Widłak P
    Acta Biochim Pol; 2014; 61(2):325-31. PubMed ID: 24872961
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of peptide cancer signatures identified by mass spectrometry in serum of patients with head and neck, lung and colorectal cancers: association with tumor progression.
    Pietrowska M; Polańska J; Suwiński R; Wideł M; Rutkowski T; Marczyk M; Domińczyk I; Ponge L; Marczak L; Polański A; Widłak P
    Int J Oncol; 2012 Jan; 40(1):148-56. PubMed ID: 21894432
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Search for potential gastric cancer biomarkers using low molecular weight blood plasma proteome profiling by mass spectrometry].
    Shevchenko VE; Arnotskaia NE; Ogorodnikova EV; Davydov MM; Ibraev MA; Turkin IN; Davydov MI
    Biomed Khim; 2014; 60(4):503-14. PubMed ID: 25249535
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mass spectrometry-based serum proteome pattern analysis in molecular diagnostics of early stage breast cancer.
    Pietrowska M; Marczak L; Polanska J; Behrendt K; Nowicka E; Walaszczyk A; Chmura A; Deja R; Stobiecki M; Polanski A; Tarnawski R; Widlak P
    J Transl Med; 2009 Jul; 7():60. PubMed ID: 19594898
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Down-regulated expression of complement factor I: a potential suppressive protein for gastric cancer identified by serum proteome analysis.
    Liu W; Liu B; Xin L; Zhang Y; Chen X; Zhu Z; Lin Y
    Clin Chim Acta; 2007 Feb; 377(1-2):119-26. PubMed ID: 17067565
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum Proteome Signature of Radiation Response: Upregulation of Inflammation-Related Factors and Downregulation of Apolipoproteins and Coagulation Factors in Cancer Patients Treated With Radiation Therapy--A Pilot Study.
    Widlak P; Jelonek K; Wojakowska A; Pietrowska M; Polanska J; Marczak Ł; Miszczyk L; Składowski K
    Int J Radiat Oncol Biol Phys; 2015 Aug; 92(5):1108-1115. PubMed ID: 26031365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum peptidome profiling revealed platelet factor 4 as a potential discriminating Peptide associated with pancreatic cancer.
    Fiedler GM; Leichtle AB; Kase J; Baumann S; Ceglarek U; Felix K; Conrad T; Witzigmann H; Weimann A; Schütte C; Hauss J; Büchler M; Thiery J
    Clin Cancer Res; 2009 Jun; 15(11):3812-9. PubMed ID: 19470732
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification and confirmation of increased fibrinopeptide a serum protein levels in gastric cancer sera by magnet bead assisted MALDI-TOF mass spectrometry.
    Ebert MP; Niemeyer D; Deininger SO; Wex T; Knippig C; Hoffmann J; Sauer J; Albrecht W; Malfertheiner P; Röcken C
    J Proteome Res; 2006 Sep; 5(9):2152-8. PubMed ID: 16944926
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proteomic analysis reveals differentially secreted proteins in the urine from patients with clear cell renal cell carcinoma.
    Sandim V; Pereira Dde A; Kalume DE; Oliveira-Carvalho AL; Ornellas AA; Soares MR; Alves G; Zingali RB
    Urol Oncol; 2016 Jan; 34(1):5.e11-25. PubMed ID: 26420021
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The MALDI-TOF mass spectrometric view of the plasma proteome and peptidome.
    Hortin GL
    Clin Chem; 2006 Jul; 52(7):1223-37. PubMed ID: 16644871
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimizing of MALDI-ToF-based low-molecular-weight serum proteome pattern analysis in detection of breast cancer patients; the effect of albumin removal on classification performance.
    Pietrowska M; Marczak L; Polanska J; Nowicka E; Behrent K; Tarnawski R; Stobiecki M; Polanski A; Widlak P
    Neoplasma; 2010; 57(6):537-44. PubMed ID: 20845992
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Five serum proteins identified using SELDI-TOF-MS as potential biomarkers of gastric cancer.
    Lu HB; Zhou JH; Ma YY; Lu HL; Tang YL; Zhang QY; Zhao CH
    Jpn J Clin Oncol; 2010 Apr; 40(4):336-42. PubMed ID: 20089528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of carboxyl terminal peptide of Fibrinogen as a potential serum biomarker for gastric cancer.
    Wu C; Luo Z; Tang D; Liu L; Yao D; Zhu L; Wang Z
    Tumour Biol; 2016 May; 37(5):6963-70. PubMed ID: 26662807
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of alternative analytical techniques for the characterisation of the human serum proteome in HUPO Plasma Proteome Project.
    Li X; Gong Y; Wang Y; Wu S; Cai Y; He P; Lu Z; Ying W; Zhang Y; Jiao L; He H; Zhang Z; He F; Zhao X; Qian X
    Proteomics; 2005 Aug; 5(13):3423-41. PubMed ID: 16052619
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum proteome profiling reveals SOX3 as a candidate prognostic marker for gastric cancer.
    Shen J; Zhai J; Wu X; Xie G; Shen L
    J Cell Mol Med; 2020 Jun; 24(12):6750-6761. PubMed ID: 32363730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MALDI-TOF-MS analysis in discovery and identification of serum proteomic patterns of ovarian cancer.
    Swiatly A; Horala A; Hajduk J; Matysiak J; Nowak-Markwitz E; Kokot ZJ
    BMC Cancer; 2017 Jul; 17(1):472. PubMed ID: 28683725
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum peptidome profiling in patients with gastric cancer.
    Yang J; Song YC; Dang CX; Song TS; Liu ZG; Guo YM; Li ZF; Huang C
    Clin Exp Med; 2012 Jun; 12(2):79-87. PubMed ID: 21739109
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of proteins in human pancreatic cancer serum using differential gel electrophoresis and tandem mass spectrometry.
    Yu KH; Rustgi AK; Blair IA
    J Proteome Res; 2005; 4(5):1742-51. PubMed ID: 16212428
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proteome profiling reveals gender differences in the composition of human serum.
    Miike K; Aoki M; Yamashita R; Takegawa Y; Saya H; Miike T; Yamamura K
    Proteomics; 2010 Jul; 10(14):2678-91. PubMed ID: 20480504
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.